Jiang W - Search Results

1

MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.

Jiang W, Wei K, Pan C, Li H, Cao J, Han X, Tang Y, Zhu S, Yuan W, He Y, Xia Y, Chen L, Chen Y. Jiang W, et al. Cell Prolif. 2018 Dec;51(6):e12502. doi: 10.1111/cpr.12502. Epub 2018 Aug 2. Cell Prolif. 2018. PMID: 30069987 Free PMC article.

2

Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC.

Liang Y, Wang N, Zhang Y, Jiang W, Fang C, Feng Y, Ma H, Jiang F, Dong G. Liang Y, et al. Among authors: jiang w, jiang f. Cell Death Dis. 2022 Oct 15;13(10):873. doi: 10.1038/s41419-022-05288-5. Cell Death Dis. 2022. PMID: 36243874 Free PMC article.

3

MRPL42 is activated by YY1 to promote lung adenocarcinoma progression.

Jiang W, Zhang C, Kang Y, Yu X, Pang P, Li G, Feng Y. Jiang W, et al. J Cancer. 2021 Mar 1;12(8):2403-2411. doi: 10.7150/jca.52277. eCollection 2021. J Cancer. 2021. PMID: 33758616 Free PMC article.

4

Neoadjuvant treatment of pembrolizumab plus platinum-doublet chemotherapy in stage IIIA squamous cell carcinoma of the lung: a case report.

Zhang C, Jiang W, Li G, Li J, Kang Y, Yu X, Ma H, Feng Y. Zhang C, et al. Among authors: jiang w. Ann Palliat Med. 2021 Mar;10(3):3510-3517. doi: 10.21037/apm-21-335. Ann Palliat Med. 2021. PMID: 33849133 Free article.

5

P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR.

Fang C, Liang Y, Huang Y, Jiang D, Li J, Ma H, Guo L, Jiang W, Feng Y. Fang C, et al. Among authors: jiang d, jiang w. Cancers (Basel). 2022 Jul 1;14(13):3243. doi: 10.3390/cancers14133243. Cancers (Basel). 2022. PMID: 35805016 Free PMC article.

6

Exploring the Mechanisms and Preventive Strategies for the Progression from Idiopathic Pulmonary Fibrosis to Lung Cancer: Insights from Transcriptomics and Genetic Factors.

Xie K, Tan X, Chen Z, Yao Y, Luo J, Ma H, Feng Y, Jiang W. Xie K, et al. Among authors: jiang w. Biomedicines. 2024 Oct 18;12(10):2382. doi: 10.3390/biomedicines12102382. Biomedicines. 2024. PMID: 39457694 Free PMC article.

7

The roles and mechanisms of the circular RNA circ_104640 in early-stage lung adenocarcinoma: a potential diagnostic and therapeutic target.

Jiang W, Zhang C, Kang Y, Li G, Feng Y, Ma H. Jiang W, et al. Ann Transl Med. 2021 Jan;9(2):138. doi: 10.21037/atm-20-8019. Ann Transl Med. 2021. PMID: 33569440 Free PMC article.

8

A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma.

Xie K, Wang B, Pang P, Li G, Yang Q, Fang C, Jiang W, Feng Y, Ma H. Xie K, et al. Among authors: jiang w. Cancer Biomark. 2024 Feb 12. doi: 10.3233/CBM-230276. Online ahead of print. Cancer Biomark. 2024. PMID: 38517776

9

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.

Jiang W, Xu J, Liao Z, Li G, Zhang C, Feng Y. Jiang W, et al. Front Cell Dev Biol. 2021 Mar 18;9:655950. doi: 10.3389/fcell.2021.655950. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33869220 Free PMC article.

10

Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinoma.

Huang H, Li N, Liang Y, Li R, Tong X, Xiao J, Tang H, Jiang D, Xie K, Fang C, Chen S, Li G, Wang B, Wang J, Luo H, Guo L, Ma H, Jiang W, Feng Y. Huang H, et al. Among authors: jiang d, jiang w. Clin Transl Med. 2023 Nov;13(11):e1493. doi: 10.1002/ctm2.1493. Clin Transl Med. 2023. PMID: 38009315 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,395 results

Search Page

Filters